ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1456

Exploring the RA Bone Marrow Niche by Single-cell Technology to Identify Long Lived ACPA+ Plasma Cells

Khaled Amara1, Aase Hensvold2, Radha Thyagarajan1, Lena Israelsson1, Johanna Steen1, Heidi Wähämaa1, Monika Hansson1, Marianne Engström1, Annika van Vollenhoven1, Anca Catrina2, Vivianne Malmström3 and Caroline Grönwall1, 1Karolinska Institutet, Stockholm, Sweden, 2Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 3Karolinska Institutet, Stockholm, Stockholms Lan, Sweden

Meeting: ACR Convergence 2020

Keywords: Anti-CCP, Anti-citrullinated Protein Autoantibodies (ACPAs), Autoantibody(ies), B-Lymphocyte, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: B Cell Biology & Targets in Autoimmune & Inflammatory Disease (1452–1456)

Session Type: Abstract Session

Session Time: 10:00AM-10:50AM

Background/Purpose: Autoantibodies is a hallmark of rheumatoid arthritis, placing the adaptive immune system and B-cells centrally in the pathogenesis. The anti-citrullinated autoantibodies (ACPA) detected in the serum can be produced either by circulating plasma blasts, locally residing plasma cells the joint, or long-lived plasma cells in the bone marrow (BM). Here we use different single cell methods to investigate the bone marrow niche.

Methods: Bone marrow samples from proximal femur in RA patients undergoing hip joint replacement was processed to isolate mononuclear cells. In total four CCP2+ and one CCP2- RA patients were investigated. All patients were HLA shared epitope positive. Firstly, CD138+ plasma cells were single cell sorted by flow cytometry followed by BCR sequencing. For two of the RA patients, MACS enriched BM B cell and peripheral B cells were further investigated by 10X Genomics Chromium methodology for single-cell RNAseq profiling and immunoglobulin sequencing. Selected paired heavy-light Ig-chains with N-glycosylation sites and high somatic hypermutation level were subsequently expressed as recombinant IgG and investigated for citrulline reactivity using an autoantigen array.

Results: For the single-cell sorted CD138+ cells, in total 509 complete IgG+ BCR sequences were generated and 44 monoclonal IgG were expressed (36 from CCP+ RA). Among the mAbs, two clones from two different patients were identified as CCP2+. One of these originated from an IgG4+ plasma cell and had strong reactivity and multi-specificity for different cit-peptides (e.g. cit-fibrinogen, cit-tenascin C, cit-hnRNP derived). 10X cell capture of 8391 BM B-cells from the same patient, generated 856 Ig with a RNAseq plasma cell profile (i.e. CD27+ XBP1+ MZB+ DERL3+ JCHAIN+ SSR4+) from 832 unique clones defined by paired HCDR3-LCDR3, occurring 1-6 times. Five 10X clones whereof two in plasma cell clusters were overlapping with the single cell sort (N=92). We observed a high frequency of both Fab glycosylation (31% of IgG+ plasma cells) and IgG4+ cells (6% of IgG+ plasma cells). Notably, also IgA+ plasma cells could be identified (37% IgA1+ 3% IgA2+). In comparison, by 10X, 24% BM IgG+ plasma cells from the CCP2- patient had Fab N-glyc sites and no IgG4+ were detected. We found no direct BCR overlap with the BM plasma cells in investigated paired peripheral B cells.

Conclusion: ACPA+ long lived plasma cells can be found in the bone marrow niche and BM-derived ACPA display multi-reactivity profiles as also seen in synovial ACPA+ plasma cells [1-2]. However, they may be relatively rare and no large clonal expansions were found. In the bone marrow, similar to blood, B-cell repertoire skewing with increased N-glycosylation and IgG4 frequencies can be observed. 

References:

[1] Steen, J., et al Recognition of amino acid motifs, rather than specific proteins, by human plasma cell-derived monoclonal antibodies to posttranslationally modified proteins in rheumatoid arthritis. Arthritis Rheumatol. 2019

[2] Sahlström, P., et al. Different hierarchies of anti-modified protein autoantibody reactivities in rheumatoid arthritis. Arthritis Rheumatol. 2020


Disclosure: K. Amara, None; A. Hensvold, None; R. Thyagarajan, None; L. Israelsson, None; J. Steen, None; H. Wähämaa, None; M. Hansson, None; M. Engström, None; A. van Vollenhoven, None; A. Catrina, None; V. Malmström, Pfizer, 2; C. Grönwall, None.

To cite this abstract in AMA style:

Amara K, Hensvold A, Thyagarajan R, Israelsson L, Steen J, Wähämaa H, Hansson M, Engström M, van Vollenhoven A, Catrina A, Malmström V, Grönwall C. Exploring the RA Bone Marrow Niche by Single-cell Technology to Identify Long Lived ACPA+ Plasma Cells [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/exploring-the-ra-bone-marrow-niche-by-single-cell-technology-to-identify-long-lived-acpa-plasma-cells/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/exploring-the-ra-bone-marrow-niche-by-single-cell-technology-to-identify-long-lived-acpa-plasma-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology